TY  - JOUR
AU  - Martin-Gutierrez, G.
AU  - Docobo-Perez, F.
AU  - Rodriguez-Beltran, J.
AU  - Rodriguez-Martinez, J. M.
AU  - Aznar, J.
AU  - Pascual, A.
AU  - Blazquez, J.
PY  - 2018
DO  - 10.1128/AAC.01899-17
SN  - 0066-4804
UR  - http://hdl.handle.net/10668/19005
T2  - Antimicrobial agents and chemotherapy
AB  - The steps by which Escherichia coli strains harboring mutations related to fosfomycin (FOS) resistance arise and spread during urinary tract infections (UTIs) are far from being understood. The aim of this study was to evaluate the effects of urine,...
LA  - en
PB  - Amer soc microbiology
KW  - fosfomycin activity
KW  - fosfomycin resistance
KW  - chromosomal mutations
KW  - UTI
KW  - Escherichia coli
KW  - urinary tract infection
KW  - Resistant klebsiella-pneumoniae
KW  - Dose oral treatment
KW  - Intravenous fosfomycin
KW  - Bacterial-growth
KW  - Infections
KW  - Impact
KW  - Tissue
KW  - Phosphonomycin
KW  - Susceptibility
KW  - Epidemiology
KW  - Escherichia coli
KW  - Fosfomycin Resistance
KW  - Urinary Tract Infections
KW  - Gene Mutation
KW  - Drug Transport Proteins
KW  - Body Fluid pH
TI  - Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake
TY  - research article
VL  - 62
ER  -